J Lipid Atheroscler.
2023 Sep;12(3):237-251. 10.12997/jla.2023.12.3.237.
Dyslipidemia Fact Sheet in South Korea, 2022
- Jin ES
1 - Shim JS2
- Kim SE3
- Bae JH4
- Kang S5
- Won JC6
- Shin MJ7
- Jin HY8
- Moon J9
- Lee H2
- Kim HC2
- Jeong IK10
- on behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis
- Affiliations
-
- 1Department of Cardiology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea
- 2Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
- 3Division of Cardiology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
- 4Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
- 5Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Yonsei University, Seoul, Korea
- 6Department of Internal Medicine, Sanggye Paik Hospital, Inje University School of Medicine, Seoul, Korea
- 7School of Biosystem and Biomedical Science, Korea University, Seoul, Korea
- 8Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical School, Jeonbuk National University, Jeonju, Korea
- 9Department of Public Health, Yonsei University Graduate School, Seoul, Korea
- 10Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea
- KMID: 2546557
- DOI: http://doi.org/10.12997/jla.2023.12.3.237
Abstract
Objective
This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.
Methods
We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ≥20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.
Results
In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ≥240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia (more than one out of three conditions [low-density lipoprotein-cholesterol ≥160 or the use of a lipid-lowering drug, triglycerides ≥200, or high-density lipoprotein-cholesterol (men and women) <40 mg/ dL]) was 40.2% between 2016 and 2020. However, it increased to 48.2% when the definition of hypo-high-density lipoprotein-cholesterolemia in women changed from <40 to <50 mg/dL.
Conclusion
Although the prevalence of hypercholesterolemia and dyslipidemia has steadily increased in South Korea, the treatment rate remains low. Therefore, continuous efforts are needed to manage dyslipidemia through cooperation between the national healthcare system, patients, and healthcare providers.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
- Dementia Epidemiology Fact Sheet 2022
- Dyslipidemia Fact Sheet in South Korea, 2022
- Obesity Fact Sheet in Korea, 2020: Prevalence of Obesity by Obesity Class from 2009 to 2018
- Fact Sheet on Cardiac Rehabilitation for Cardiovascular Disease in South Korea
